Research funder · United States
Michael J. Fox Foundation for Parkinson's Research
Non-profit organization in the USA
- Grants since 2016
- 1 275
- Awarded, last 5 years (where amounts are published)
- —
- Funded works, last 5 years
- 3 085
- Funded works, all time
- 6 716
Grants
2020 · research · Research Grant
California Parkinson’s Disease Registry
Mark Damesyn · California Department of Public Health
2020 · research · Aligning Science Across Parkinson's
Mechanisms of Mitochondrial Damage Control by PINK1 and Parkin
James Herschel Hurley · University of California, Berkeley
2020 · research · Research Grant
Identification of Therapeutic Circuits to Address Anxiety and Depression Symptoms in Parkinson’s Disease
Kimberly R. Thompson · Maplight Therapeutics
2020 · research · Therapeutic Pipeline Program
Developing TMEM175 Activators as Therapeutics for Parkinson's Disease
Magdalene M. Moran · Caraway Therapeutics, Inc.
2020 · research · Target Advancement Program
Evaluating the Role of Natural Killer Cells in Parkinson's Pathology
Jae-Kyung Lee · University of Georgia
2020 · research · Therapeutic Pipeline Program
Anle138b Clinical Phase 1 Studies: Food Effect, Safety and Tolerability as well as Pharmacokinetics in Parkinson´s Disease Patients
Johannes Levin · Lmu Klinikum, Department Of Neurology
2020 · research · Research Grant
Cytokine Production by Adaptive Immune Cells in Parkinson’s Disease: Response to Diverse Biological Stimuli
Etty (Tika) N. Benveniste · University of Alabama at Birmingham
2020 · research · Therapeutic Pipeline Program
Target Validation Studies for the Discovery of Novel Small Molecule Therapeutics with the Potential to Modify Disease Outcome by Inhibiting Bacterial Amyloid Protein-induced Alpha-synuclein Aggregation and Associated Neuronal Toxicity
Anthony Stewart Campbell · Axial Therapeutics, Inc.
2020 · research · Improved Biomarkers and Clinical Outcome Measures
Developing Assays to Quantify Cys106 of DJ-1 in Distinct Oxidized States as a Potential Diagnostic Tool for Parkinson’s Disease
Gergely Toth · Cantabio Pharmaceuticals
2020 · research · Aligning Science Across Parkinson's
From Cancer Associations to Altered Immunity in the Pathogenesis of Parkinson’s Disease
Xiqun Chen · Massachusetts General Hospital
2020 · research · Research Grant
Safety and Tolerability of NLX-112 in People with Parkinson’s
Adrian Newman-Tancredi · Neurolixis (United States)
2020 · research · Aligning Science Across Parkinson's
Co-Pathologies Drive Neuroinflammation and Progression in PD
Jeffrey H. Kordower · Rush University Medical Center
2020 · research · Therapeutic Pipeline Program
Pre-clinical Development of Compounds that Modulate Mitophagy through Regulation of the Mitochondrial GTPase Miro1
William Dvořák Shrader · Acurex Therapeutics Corporation
2020 · research · Access to Data and Biospecimens
Development of a Biomarker Platform for Parkinson’s Disease Using Patient-derived Cells
Lalitha Madhavan · University of Arizona
2020 · research · Research Grant
GBA Variations, Cholinergic Degeneration, and Cognitive Decline in Parkinson’s Disease
Teus Van Laar · University of Groningen
2020 · research · Biosample Use Program
Metabolomic Analysis of Penetrance, Prognosis and Tracking Biomarkers of LRRK2 PD
Michael A. Schwarzschild · Massachusetts General Hospital
2020 · research · Target Advancement Program
The Role of Cannabinoid Receptor 2 in Inflammatory Responses Triggered by Alpha-synuclein
Valerie Joers · University of Florida
2020 · research · Aligning Science Across Parkinson's
Defining the Cellular and Molecular Determinants of Variable Genetic Penetrance in Parkinson’s Disease
Lorenz Studer · Memorial Sloan Kettering Cancer Center
2020 · research · Alpha-Synuclein Imaging
Alpha-Synuclein PET Tracer Discovery
Anthony Jon Roecker · Merck & Co., Inc., Rahway, NJ, USA (United States)
2020 · research · Therapeutic Pipeline Program
Therapeutic Swallow Sensor
Shuai Xu · Sonica Llc
2020 · research · Research Grant
Alpha-synuclein Toxicity in LRRK2 Knock-in Models and Rescue by LRRK2 Silencing
Austen James Milnerwood · University of British Columbia
2020 · research · Research Grant
Molecular Basis of Neurodegeneration in GBA-associated Parkinson’s Disease
Monther Abu-Remaileh · Stanford University
2020 · research · Biosample Use Program
Adaptive Immune Markers for Predicting Cognitive Decline in Parkinson’s Disease
Marion S. Buckwalter · Department Of Neurology And Neurological Sciences And Department Of Neurosurgery, Stanford Universit
2020 · research · Research Grant
Parkinson’s Disease with Mild Cognitive Impairment Treated with a Nicotinic Agonist Drug
Dag Aarsland · King's College London
2020 · research · Research Grant
Parkinson’s Disease Subtyping by Genetic and Intestinal Inflammation Biomarkers
Inga Peter · Icahn School of Medicine at Mount Sinai
2020 · research · Aligning Science Across Parkinson's
Dissecting the Mechanisms Underlying Disease Progression
John Anthony Hardy · UCL Queen Square Institute of Neurology
2020 · research · Therapeutic Pipeline Program
Photoreceptor-Directed Light Therapy in Parkinson’s Disease
Beatrix Feigl · Queensland University of Technology
2020 · research · Research Grant Supplement
Developing Biosignatures for Parkinson's Disease Using Sense of Smell (Supplement)
Charlotte D'Hulst · Yesse Technologies, Inc.
2020 · research · Therapeutic Pipeline Program
Identification and Characterization of Small Molecule Activators of ATP13A2 for Parkinson’s Disease Therapy
Peter Vangheluwe · KU Leuven
2020 · research · Improved Biomarkers and Clinical Outcome Measures
Assessment of Brain Tau Burden in Parkinson's Disease with or without a LRRK2 Mutation using [18F]MK-6240 PET Imaging
David Russell · Institute for Neurodegenerative Disorders
2020 · research · Research Grant
Biomarker for Mitophagy Pathway Activation
Wolfdieter Springer · Mayo Clinic
2020 · research · Aligning Science Across Parkinson's
Cellular Mechanism of LRRK2 in Health and Disease
Samara Reck-Peterson · University of California San Diego
2020 · research · Aligning Science Across Parkinson's
Tracing the Origin and Progression of Parkinson’s Disease through the Neuro-immune Interactome
David A. Hafler · Yale University
2020 · research · Aligning Science Across Parkinson's
Adaptive Immunity in the Etiology and Progression of Parkinson’s Disease
David Sulzer · Research Foundation For Mental Hygiene/ New York State Psychiatric Institute/ Columbia University
2020 · research · Research Grant Supplement
LIMP-2 as a Scaffolding Protein to Characterize PD-Associated GCase Variants
Friederike Zunke · Universitätsklinikum Erlangen, Department Of Molecular Neurology
2020 · research · Research Grant Supplement
Discovery of Selective PET Imaging Agents for Tauopathies and Alpha-Synuclein
Chester A. Mathis · University of Pittsburgh
2019 · research · Non-pharmacological Interventions for Gait and Balance
Wearable Airbag Technology to Mitigate Falls in Individuals with Parkinson’s Disease
Arun Jayaraman · Mäx Nader Lab For Rehabilitation Technologies & Outcomes Research
2019 · research · Non-pharmacological Interventions for Gait and Balance
DeFOG: Digital wearable walking aid for freezing of gait
Alice Nieuwboer · KU Leuven
2019 · research · Non-pharmacological Interventions for Gait and Balance
StandingTall-PD. An engaging neuro-rehabilitation program using eHealth technologies to reduce step-time variability, prevent freezing of gait and falls, and enhance independence in people with Parkinson's disease: A placebo randomized controlled trial
Kim Delbaere · Neuroscience Research Australia
2019 · research · Non-pharmacological Interventions for Gait and Balance
Optimizing Vibration Therapy to Improve Gait and Balance in Parkinson's Disease
Ingrid Pretzer-Aboff · Virginia Commonwealth University